Related Experiment Videos
[Gelsolin level for prognostic evaluation in patients with critically illness]
Xiao-qin Zhang1, Hong Pu2, Yi-ping Wang2
1Intensive Care Unit，Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital，Chengdu 610072，China.
Summary
Plasma gelsolin levels are significantly lower in critically ill patients. Lower plasma gelsolin indicates a poorer prognosis, making it a valuable indicator for critical illness outcomes.
Area of Science:
- Biochemistry
- Critical Care Medicine
- Prognostic Biomarkers
Background:
- Critical illness is associated with complex physiological changes.
- Identifying reliable prognostic markers is crucial for patient management.
Purpose of the Study:
- To investigate plasma gelsolin level changes in critically ill patients.
- To evaluate the application of plasma gelsolin as a prognostic indicator.
Main Methods:
- Prospective cohort study of 96 critically ill patients and 186 healthy controls.
- Plasma gelsolin levels measured using enzyme-linked immunosorbent assay (ELISA) at multiple time points.
- Logistic regression analysis to assess the relationship between gelsolin levels and prognosis.
Main Results:
- Critically ill patients exhibited significantly lower plasma gelsolin levels compared to controls (P<0.01).
- Plasma gelsolin levels differed significantly between survival and fatal patient groups (P<0.01).
- A negative correlation was observed between plasma gelsolin levels and fatal outcomes (r=-0.512, P<0.01).
Conclusions:
- Plasma gelsolin levels correlate with the severity of critical illness.
- Plasma gelsolin serves as a potential prognostic indicator for critically ill patients.